UFMylation: A supervisor of the HIF1α pathway and a potential therapeutic target for anti-PD-1 combination therapy in hypoxic tumors

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2500562122
Affiliations:
6
Authors:
18
Go to article
Institutions Authors Share
Guangdong Medical University (GDMU), China
9.000000
 0.50
Hangzhou Normal University (HZNU), China
3.000000
 0.17
Institute of Cancer Research, Shenzhen Bay Laboratory, China
2.000000
 0.11
GMU-GIBH Joint School of Life Sciences, China
2.000000
 0.11
Nanjing Agricultural University (NAU), China
1.500000
 0.08
Shandong Academy of Agricultural Sciences, China
0.500000
 0.03
Interested in Medical Biochemistry and Metabolomics?